Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-19

Clinical Trial Update: Inulin and S. Salivarius Reduce Halitosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing inulin and S. salivarius for reducing halitosis; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Inulin (inulin)
  • Streptococcus salivarius

Snippet

Sponsor: Universidade de Passo Fundo | Conditions: Halitosis, Tongue Diseases | Phase 2 | Status: COMPLETED | Results posted: 2020-08-19